What caused the TLIK.F stock spike pre-market on 19 Feb 2026?

The spike reflects thin liquidity and short-term buying interest; volume rose to **958** versus an average **694**. No formal earnings release was listed, so mechanics are likely event-driven or order-book moves rather than published news.

What is Meyka AI's forecast for TLIK.F stock?

Meyka AI's forecast model projects a monthly price of **€0.27** and a quarterly price of **€0.51**. The quarterly target implies a **29.44%** upside from **€0.39**. Forecasts are model-based projections and not guarantees.

How risky is trading TLIK.F stock right now?

Trading TLIK.F stock is high risk due to low market cap **€2,455,967.00**, thin liquidity, negative EPS **-€0.11**, and weak current ratio **0.04**. Price can gap widely on small orders or news.

Where can I find official company information for TLIK.F stock?

Official details are on the company site at [Arzneiwerk AG VIDA](https://www.arzneiwerk.ag). Financial snapshots and the instrument image are available via the profile link at FinancialModelingPrep.

DE Stocks

TLIK.F Arzneiwerk AG (XETRA) up 50% pre-market 19 Feb 2026: 0.51 EUR target

ByHuzaifa Zahoor February 19, 2026February 19, 2026

TLIK.F stock jumped 50.38% in pre-market trade on XETRA on 19 Feb 2026, trading at €0.39 after an open at €0.39. The move lifted volume to 958 shares versus an average 694. Investors are pricing a short-term re-rating after thin liquidity pushed intraday volatility. We track valuation, technicals, and Meyka AI forecasts to explain the spike and next levels for Arzneiwerk AG VIDA in Germany.